APA (7th ed.) Citation

Zhou, H., Yin, Q., Jin, J., Liu, T., Cai, Z., Jiang, B., . . . Wang, J. (2022). Efficacy and safety of blinatumomab in Chinese adults with Ph-negative relapsed/refractory B-cell precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China registrational study. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Zhou, Hongsheng, et al. Efficacy and Safety of Blinatumomab in Chinese Adults with Ph-negative Relapsed/refractory B-cell Precursor Acute Lymphoblastic Leukemia: A Multicenter Open-label Single-arm China Registrational Study. Taylor & Francis Group, 2022.

MLA (9th ed.) Citation

Zhou, Hongsheng, et al. Efficacy and Safety of Blinatumomab in Chinese Adults with Ph-negative Relapsed/refractory B-cell Precursor Acute Lymphoblastic Leukemia: A Multicenter Open-label Single-arm China Registrational Study. Taylor & Francis Group, 2022.